Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_assertion type Assertion NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_head.
- NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_assertion wasGeneratedBy ECO_0000203 NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_provenance.
- NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_assertion wasDerivedFrom befree-20150227 NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_provenance.
- NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_assertion SIO_000772 24627085 NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_provenance.
- NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_assertion evidence source_evidence_literature NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_provenance.
- NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_assertion description "[The veliparib and CPT-11 combination can be further explored as a treatment of metastatic castration-resistant prostate cancers that have frequent p53 mutations and enriched genomic instability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925948.RAkymDrNRSXUUErOrhtv5cSOMAusSXAAJmGUmVZUv4ntw130_provenance.